Neuland Laboratories Beneish M-Score Historical Data
The historical data trend for Neuland Laboratories's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neuland Laboratories Beneish M-Score Chart
|
Neuland Laboratories Annual Data
|
|
Trend |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
Mar24 |
| Beneish M-Score |
|
Get a 7-Day Free Trial
|
|
|
-2.60 |
-2.92 |
-2.43 |
-2.39 |
-2.16 |
|
Neuland Laboratories Quarterly Data
|
|
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
| Beneish M-Score |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
-2.39 |
- |
- |
- |
-2.16 |
Competitive Comparison of Neuland Laboratories's Beneish M-Score
For the Drug Manufacturers - Specialty & Generic subindustry, Neuland Laboratories's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neuland Laboratories's Beneish M-Score Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Neuland Laboratories's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Neuland Laboratories's Beneish M-Score falls into.
Neuland Laboratories Beneish M-Score Calculation
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Neuland Laboratories for today is based on a combination of the following eight different indices:
| M | = | -4.84 | + | 0.92 * DSRI | + | 0.528 * GMI | + | 0.404 * AQI | + | 0.892 * SGI | + | 0.115 * DEPI |
| = | -4.84 | + | 0.92 * 0.7677 | + | 0.528 * 0.916 | + | 0.404 * 0.9211 | + | 0.892 * 1.3084 | + | 0.115 * 1.0085 |
| - | 0.172 * SGAI | + | 4.679 * TATA | - | 0.327 * LVGI |
| - | 0.172 * 0 | + | 4.679 * 0.021228 | - | 0.327 * 0.8033 |
| = | -2.16 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| This Year (Mar24) TTM: | Last Year (Mar23) TTM: |
Total Receivables was ₹3,735 Mil.
Revenue was ₹15,586 Mil.
Gross Profit was ₹8,248 Mil.
Total Current Assets was ₹9,211 Mil.
Total Assets was ₹18,326 Mil.
Property, Plant and Equipment(Net PPE) was ₹5,686 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹597 Mil.
Selling, General, & Admin. Expense(SGA) was ₹0 Mil.
Total Current Liabilities was ₹4,277 Mil.
Long-Term Debt & Capital Lease Obligation was ₹541 Mil.
Net Income was ₹3,001 Mil.
Gross Profit was ₹0 Mil.
Cash Flow from Operations was ₹2,612 Mil.
|
Total Receivables was ₹3,719 Mil.
Revenue was ₹11,912 Mil.
Gross Profit was ₹5,774 Mil.
Total Current Assets was ₹7,609 Mil.
Total Assets was ₹15,798 Mil.
Property, Plant and Equipment(Net PPE) was ₹4,980 Mil.
Depreciation, Depletion and Amortization(DDA) was ₹528 Mil.
Selling, General, & Admin. Expense(SGA) was ₹559 Mil.
Total Current Liabilities was ₹4,390 Mil.
Long-Term Debt & Capital Lease Obligation was ₹781 Mil.
|
1. DSRI = Days Sales in Receivables Index
Measured as the ratio of Revenue in Total Receivables in year t to year t-1.
A large increase in DSR could be indicative of revenue inflation.
| DSRI | = | (Receivables_t / Revenue_t) | / | (Receivables_t-1 / Revenue_t-1) |
| = | (3735.262 / 15585.805) | / | (3718.665 / 11911.98) |
| = | 0.239658 | / | 0.312179 |
| | = | 0.7677 |
2. GMI = Gross Margin Index
Measured as the ratio of gross margin in year t-1 to gross margin in year t.
Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.
| GMI | = | GrossMargin_t-1 | / | GrossMargin_t |
| = | (GrossProfit_t-1 / Revenue_t-1) | / | (GrossProfit_t / Revenue_t) |
| = | (5774.127 / 11911.98) | / | (8247.838 / 15585.805) |
| = | 0.484733 | / | 0.529189 |
| | = | 0.916 |
3. AQI = Asset Quality Index
AQI is the ratio of asset quality in year t to year t-1.
Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.
| AQI | = | (1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) | / | (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1) |
| = | (1 - (9210.807 + 5686.124) / 18325.61) | / | (1 - (7608.941 + 4979.98) / 15797.645) |
| = | 0.187098 | / | 0.203114 |
| | = | 0.9211 |
4. SGI = Sales Growth Index
Ratio of Revenue in year t to sales in year t-1.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
| SGI | = | Sales_t | / | Sales_t-1 |
| = | Revenue_t | / | Revenue_t-1 |
| = | 15585.805 | / | 11911.98 |
| | = | 1.3084 |
5. DEPI = Depreciation Index
Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
| DEPI | = | (Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) | / | (Depreciation_t / (Depreciaton_t + PPE_t)) |
| = | (527.774 / (527.774 + 4979.98)) | / | (596.999 / (596.999 + 5686.124)) |
| = | 0.095824 | / | 0.095016 |
| | = | 1.0085 |
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.
SGA expenses index > 1 means that the company is becoming less efficient in generate sales.
| SGAI | = | (SGA_t / Sales_t) | / | (SGA_t-1 /Sales_t-1) |
| = | (0 / 15585.805) | / | (558.717 / 11911.98) |
| = | 0 | / | 0.046904 |
| | = | 0 |
7. LVGI = Leverage Index
The ratio of total debt to Total Assets in year t relative to yeat t-1.
An LVGI > 1 indicates an increase in leverage
| LVGI | = | ((LTD_t + CurrentLiabilities_t) / TotalAssets_t) | / | ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1) |
| = | ((541.24 + 4276.832) / 18325.61) | / | ((780.934 + 4389.57) / 15797.645) |
| = | 0.262915 | / | 0.327296 |
| | = | 0.8033 |
8. TATA = Total Accruals to Total Assets
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
| TATA | = | (IncomefromContinuingOperations_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
| = | (NetIncome_t - NonOperatingIncome_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
| = | (3000.789 - 0 | - | 2611.767) | / | 18325.61 |
| | = | 0.021228 |
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Neuland Laboratories has a M-score of -2.16 suggests that the company is unlikely to be a manipulator.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:524558 has been successfully added to your